OptioBio - SARS CoV-2 nAb Rapid Diagnostic Test

 

OptiBio - SARS CoV-2 nAb Rapid Diagnostic Test

 

SARS CoV-2 neutralizing antibodies (nAb) are specialized antibodies that block SARS CoV-2 from binding to our cells. SARS CoV-2 vaccines ultimately aim to incite growth of neutralizing antibodies to develop acquired immunity in patients.

Optical Q SARS CoV-2 nAb detection kit is a breakthrough fluorescence immunoassay (FIA) solution that can quantitatively measure neutralizing antibodies in blood samples within 15 minutes. This breakthrough test kit will allow for:

* Evaluating vaccine efficacy by detecting SARS-CoV-2 neutralizing antibodies in the serum/plasma from vaccinated patients;

* Monitoring immunization by mass detecting SARS-CoV-2 neutralizing antibodies in serum/plasma of recovering COVID-19 patients.